BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1635057)

  • 1. Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.
    Patt WC; Hamilton HW; Taylor MD; Ryan MJ; Taylor DG; Connolly CJ; Doherty AM; Klutchko SR; Sircar I; Steinbaugh BA
    J Med Chem; 1992 Jul; 35(14):2562-72. PubMed ID: 1635057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.
    Repine JT; Himmelsbach RJ; Hodges JC; Kaltenbronn JS; Sircar I; Skeean RW; Brennan ST; Hurley TR; Lunney E; Humblet CC
    J Med Chem; 1991 Jul; 34(7):1935-43. PubMed ID: 2066966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors containing alpha-heteroatom amino acids as P2 residues.
    Repine JT; Kaltenbronn JS; Doherty AM; Hamby JM; Himmelsbach RJ; Kornberg BE; Taylor MD; Lunney EA; Humblet C; Rapundalo ST
    J Med Chem; 1992 Mar; 35(6):1032-42. PubMed ID: 1552498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors.
    Doherty AM; Sircar I; Kornberg BE; Quin J; Winters RT; Kaltenbronn JS; Taylor MD; Batley BL; Rapundalo SR; Ryan MJ
    J Med Chem; 1992 Jan; 35(1):2-14. PubMed ID: 1732531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-peptide renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 replacements.
    Raddatz P; Minck KO; Rippmann F; Schmitges CJ
    J Med Chem; 1994 Feb; 37(4):486-97. PubMed ID: 8120867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
    Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
    J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
    Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel renin inhibitors containing (2S,3S,5S)-2-amino-1-cyclohexyl-6-methyl-3,5-heptanediol fragment as a transition-state mimic at the P1-P1' cleavage site.
    Yamada Y; Ando K; Ikemoto Y; Tada H; Shirakawa E; Inagaki E; Shibata S; Nakamura I; Hayashi Y; Ikegami K; Uchida I
    Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1631-41. PubMed ID: 9353891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin inhibitors containing a pyridyl amino diol derived C-terminus.
    Heitsch H; Henning R; Kleemann HW; Linz W; Nickel WU; Ruppert D; Urbach H; Wagner A
    J Med Chem; 1993 Sep; 36(19):2788-800. PubMed ID: 8410992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statine-containing dipeptide and tripeptide inhibitors of human renin.
    Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y
    Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy.
    Simoneau B; Lavallée P; Anderson PC; Bailey M; Bantle G; Berthiaume S; Chabot C; Fazal G; Halmos T; Ogilvie WW; Poupart MA; Thavonekham B; Xin Z; Thibeault D; Bolger G; Panzenbeck M; Winquist R; Jung GL
    Bioorg Med Chem; 1999 Mar; 7(3):489-508. PubMed ID: 10220035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New inhibitors of human renin that contain novel replacements at the P2 site.
    Doherty AM; Kaltenbronn JS; Hudspeth JP; Repine JT; Roark WH; Sircar I; Tinney FJ; Connolly CJ; Hodges JC; Taylor MD
    J Med Chem; 1991 Apr; 34(4):1258-71. PubMed ID: 1901910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of novel imidazole alcohol inhibitors of primate renin.
    DeForrest JM; Waldron TL; Oehl RS; Scalese RJ; Free CA; Weller HN; Ryono DE
    J Hypertens Suppl; 1989 Apr; 7(2):S15-9. PubMed ID: 2666607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
    Raddatz P; Jonczyk A; Minck KO; Schmitges CJ; Sombroek J
    J Med Chem; 1991 Nov; 34(11):3267-80. PubMed ID: 1956045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of some transition-state inhibitors of human renin.
    Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
    J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement.
    Baker WR; Fung AK; Kleinert HD; Stein HH; Plattner JJ; Armiger YL; Condon SL; Cohen J; Egan DA; Barlow JL
    J Med Chem; 1992 May; 35(10):1722-34. PubMed ID: 1588554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
    Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly potent and specific inhibitors of human renin.
    Sham HL; Stein H; Rempel CA; Cohen J; Plattner JJ
    FEBS Lett; 1987 Aug; 220(2):299-301. PubMed ID: 3111889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water-soluble renin inhibitors: design of a subnanomolar inhibitor with a prolonged duration of action.
    Rosenberg SH; Woods KW; Sham HL; Kleinert HD; Martin DL; Stein H; Cohen J; Egan DA; Bopp B; Merits I
    J Med Chem; 1990 Jul; 33(7):1962-9. PubMed ID: 2194033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung.
    Shiosaki K; Tasker AS; Sullivan GM; Sorensen BK; von Geldern TW; Wu-Wong JR; Marselle CA; Opgenorth TJ
    J Med Chem; 1993 Feb; 36(4):468-78. PubMed ID: 8474103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.